Theralase Technologies Inc. (TLTFF) Financials
TLTFF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 5.7 million | 903656 |
| March 31, 2026 | 2.8 million | 1.4 million |
| Dec. 31, 2025 | 2.5 million | 1.3 million |
| Sept. 30, 2025 | 2.2 million | 1.4 million |
TLTFF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -869049 | ? |
| March 31, 2026 | -176464 | 80929 |
| Dec. 31, 2025 | -865059 | 45940 |
| Sept. 30, 2025 | -504351 | 116349 |
TLTFF Net Income
No data available :(
TLTFF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.7 million | - | 104672 |
| March 31, 2026 | 721808 | - | 126134 |
| Dec. 31, 2025 | 133417 | - | 147424 |
| Sept. 30, 2025 | 58162 | 81132 | 157797 |
TLTFF Shares Outstanding
TLTFF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3196 | 377539 | 431115 | 50871 |
| March 31, 2026 | 645 | 375691 | 368836 | 8832 |
| Dec. 31, 2025 | 30660 | 245009 | 374093 | -59737 |
| Sept. 30, 2025 | 10880 | 471189 | 375435 | 52721 |
TLTFF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 115635 | 55413 |
| March 31, 2026 | 95359 | 91679 |
| Dec. 31, 2025 | 164768 | 6997 |
| Sept. 30, 2025 | 200830 | 86738 |
TLTFF
Price: $0.12
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -21
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 36.9 million